drugset / Trial / NCT00701831

Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control

NCT00701831 ↗

Phase 4 Completed 241 enrolled Sanofi
NaSingle-groupOpen-labelTreatment

Summary

Primary objective: * To observe the efficacy of the forced titration to reach good glycemic control in Lantus treated patients Secondary objectives: * To assess the forced titration on physician and patient satisfaction * To evaluate the impact of training tools by means of patient profile

Timeline

Start
2008-05
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin glargine Protein / enzyme biologic — —